UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Natural killer cells and other innate lymphoid cells in cancer

Nature reviews. Immunology, 2018-11, Vol.18 (11), p.671

2018

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Infiltrating Natural Killer Cells

Cancer discovery, 2021-01, Vol.11 (1), p.34-44

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoints on innate lymphoid cells

The Journal of experimental medicine, 2017-06, Vol.214 (6), p.1561-1563

2017

Link zum Volltext

Verfügbarkeit prüfen

Maturation of mouse NK cells is a 4-stage developmental program

Blood, 2009-05, Vol.113 (22), p.5488-5496

2009

Link zum Volltext

Verfügbarkeit prüfen

Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more

Seminars in immunology, 2017-06, Vol.31 (SI), p.55-63

2017

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua

Frontiers in immunology, 2019-02, Vol.10, p.170-170

2019

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses

Stem cells (Dayton, Ohio), 2016-07, Vol.34 (7), p.1909-1921

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular definition of group 1 innate lymphoid cells in the mouse uterus

Nature communications, 2018-10, Vol.9 (1), p.4492-13, Article 4492

2018

Link zum Volltext

Verfügbarkeit prüfen

Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor

Nature immunology, 2007-12, Vol.8 (12), p.1337-1344

2007

Link zum Volltext

Verfügbarkeit prüfen

Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response

PloS one, 2012-06, Vol.7 (6), p.e39170

2012

Link zum Volltext

Verfügbarkeit prüfen

Bringing natural killer cells to the clinic

The Journal of experimental medicine, 2022-10, Vol.219 (10)

2022

Link zum Volltext

Verfügbarkeit prüfen

S258: IPH6501 IS A FIRST‐IN‐CLASS TETRASPECIFIC ANTIBODY‐BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B‐CELL NON‐HODGKIN’S LYMPHOMAS

HemaSphere, 2023-08, Vol.7 (S3), p.e1234532-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells

Proceedings of the National Academy of Sciences - PNAS, 2001-05, Vol.98 (10), p.5764-5769

2001

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T‐ and NK‐cell proliferation and function

European journal of immunology, 2011-11, Vol.41 (11), p.3281-3290

2011

Link zum Volltext

Verfügbarkeit prüfen

IPH6501 Is a Novel NKp46-Targeting Tetraspecific Antibody-Based Natural Killer Cell Engager Therapeutic (ANKET) Armed with a Non-Alpha IL-2 Variant and Developed for the Treatment of CD20-Positive Malignancies

Blood, 2022-11, Vol.140 (Supplement 1), p.11559-11559

2022

Link zum Volltext

Verfügbarkeit prüfen

Increased Arginase1 expression in tumor microenvironment promotes mammary carcinogenesis via multiple mechanisms

Carcinogenesis (New York), 2020-12, Vol.41 (12), p.1695-1702

2020

Link zum Volltext

Verfügbarkeit prüfen

Unique Eomes(+) NK Cell Subsets Are Present in Uterus and Decidua During Early Pregnancy

Frontiers in immunology, 2016-01, Vol.6, p.646-646

2016

Link zum Volltext

Verfügbarkeit prüfen

Murine peripheral NK‐cell populations originate from site‐specific immature NK cells more than from BM‐derived NK cells

European journal of immunology, 2016-05, Vol.46 (5), p.1258-1270

2016

Link zum Volltext

Verfügbarkeit prüfen

In vivo generation of decidual natural killer cells from resident hematopoietic progenitors

Haematologica (Roma), 2014-03, Vol.99 (3), p.448-457

2014

Link zum Volltext

Verfügbarkeit prüfen

Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2– versus IL-15–activated NK cells

Blood, 2007-05, Vol.109 (9), p.3767-3775

2007

Link zum Volltext

Verfügbarkeit prüfen

The corticosteroid‐induced inhibitory effect on NK cell function reflects down‐regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity

European journal of immunology, 2004-11, Vol.34 (11), p.3028-3038

2004

Link zum Volltext

Verfügbarkeit prüfen

Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein

Frontiers in immunology, 2012-01, Vol.3, p.239-239

2012

Link zum Volltext

Verfügbarkeit prüfen

Maturation of Mouse NK Cells is a Four-stage Developmental Program

Clinical immunology (Orlando, Fla.), 2010, Vol.135, p.S48-S48

2010

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation

European journal of immunology, 2004-02, Vol.34 (2), p.455-460

2004

Link zum Volltext

Verfügbarkeit prüfen

Human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors

Molecular immunology, 2005-02, Vol.42 (4), p.405-411

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)
Buchkapitel
(1)

Sprache

Englisch
(27)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Natural killer cells and other innate lymphoid cells in cancer

Tumor-Infiltrating Natural Killer Cells

Immune checkpoints on innate lymphoid cells

Maturation of mouse NK cells is a 4-stage developmental program

Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more

Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua

Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses

Molecular definition of group 1 innate lymphoid cells in the mouse uterus

Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor

Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response

Bringing natural killer cells to the clinic

S258: IPH6501 IS A FIRST‐IN‐CLASS TETRASPECIFIC ANTIBODY‐BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B‐CELL NON‐HODGKIN’S LYMPHOMAS

Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells

Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T‐ and NK‐cell proliferation and function

IPH6501 Is a Novel NKp46-Targeting Tetraspecific Antibody-Based Natural Killer Cell Engager Therapeutic (ANKET) Armed with a Non-Alpha IL-2 Variant and Developed for the Treatment of CD20-Positive Malignancies

Increased Arginase1 expression in tumor microenvironment promotes mammary carcinogenesis via multiple mechanisms

Unique Eomes(+) NK Cell Subsets Are Present in Uterus and Decidua During Early Pregnancy

Murine peripheral NK‐cell populations originate from site‐specific immature NK cells more than from BM‐derived NK cells

In vivo generation of decidual natural killer cells from resident hematopoietic progenitors

Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2– versus IL-15–activated NK cells

The corticosteroid‐induced inhibitory effect on NK cell function reflects down‐regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity

Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein

Maturation of Mouse NK Cells is a Four-stage Developmental Program

Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation

Human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors

Suchergebnisse filtern